WO2026127981 - ENANTIOMERIC COMPOUNDS AND METHODS FOR TREATING INVASIVE TUMORS
National phase entry is expected:
Publication Number
WO/2026/127981
Publication Date
18.06.2026
International Application No.
PCT/US2025/000041
International Filing Date
12.12.2025
Title **
[English]
ENANTIOMERIC COMPOUNDS AND METHODS FOR TREATING INVASIVE TUMORS
[French]
COMPOSÉS ÉNANTIOMÈRES ET MÉTHODES DE TRAITEMENT DE TUMEURS INVASIVES
Applicants **
BARBEAU, Donald, L.
Inventors
BARBEAU, Donald, L.
Priority Data
18/831,365
13.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2157 | |
| EPO | Filing, Examination, Granting | 9451 | |
| Japan | Filing, Examination, Granting | 2233 | |
| South Korea | Filing, Examination, Granting | 2246 | |
| USA | Filing, Examination, Granting | 6110 |
Total:
22,197
Contact Us
Abstract[English]
The present invention relates to purified enantiomers of compounds and pharmaceutical compositions for treating a subject having a cancer in need of therapy thereof comprising administering to the Subject a compound in an amount effective in inhibiting tumor growth, said compound having the formula:[French]
La présente invention concerne des énantiomères purifiés de composés et des compositions pharmaceutiques pour traiter un sujet atteint d'un cancer nécessitant une thérapie correspondante comprenant l'administration au sujet d'un composé en une quantité efficace pour inhiber la croissance tumorale, ledit composé ayant la formule :